Prostaglandins and other lipid mediators in Alzheimer's disease (Q34997956)

5 August 2017

1 reference

title

Prostaglandins and other lipid mediators in Alzheimer's disease (English)

1 reference

5 August 2017

0 references

3

Walter J Lukiw

1 reference

5 August 2017

Nicolas G Bazan

1

1 reference

5 August 2017

Vittorio Colangelo

series ordinal

2

1 reference

5 August 2017

language of work or name

1 reference

1 August 2002

1 reference

Prostaglandins and Other Lipid Mediators

5 August 2017

published in

1 reference

5 August 2017

volume

68-69

1 reference

5 August 2017

page(s)

197-210

1 reference

Alzheimer's disease: genes, proteins, and therapy

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Methodological variables in the assessment of beta amyloid neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Aggregation State and Neurotoxic Properties of Alzheimer Beta-Amyloid Peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

COX-2 as a multifunctional neuronal modulator

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Apolipoprotein E: a pharmacogenetic target for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Cellular and molecular basis of beta-amyloid precursor protein metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

The biological and pathological function of presenilin proteins--simple cell systems and a worm in Alzheimer's disease research

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Molecular genetics of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Apolipoprotein E and Alzheimer's disease. The tip of the susceptibility iceberg

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Genomic structure and expression of STM2, the chromosome 1 familial Alzheimer disease gene

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Analysis of the 5' sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Neurofilament function and dysfunction: involvement in axonal growth and neuronal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Cytoskeletal messenger RNA stability in human neocortex: studies in normal aging and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Neurofilaments in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Neurofilament functions in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

VAMP-1: a synaptic vesicle-associated integral membrane protein

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Expression of proteins linked to exocytosis and neurotransmission in patients with Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Synaptic vesicle proteins and regulated exocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Temporal cortex synaptophysin mRNA is reduced in Alzheimer's disease and is negatively correlated with the severity of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Expression profiles of multiple genes in single neurons of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Synapsin I gene expression in the adult rat brain with comparative analysis of mRNA and protein in the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Suppression of synapsin II inhibits the formation and maintenance of synapses in hippocampal culture

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Impairment of axonal development and of synaptogenesis in hippocampal neurons of synapsin I-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

COX-1 and COX-2 in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Synergy by secretory phospholipase A2 and glutamate on inducing cell death and sustained arachidonic acid metabolic changes in primary cortical neuronal cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Phospholipases and phagocytosis: the role of phospholipid-derived second messengers in phagocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Subcellular membrane impairment and application of phospholipase A2 inhibitors in endotoxic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Effects of phospholipase A2 inhibitors on Ca2+ oscillations in pancreatic acinar cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Arachidonic acid cascade and signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Mediators of injury in neurotrauma: intracellular signal transduction and gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

The neuromessenger platelet-activating factor in plasticity and neurodegeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Regulation of platelet-activating factor (PAF) activity in human diseases by phospholipase A2 inhibitors, PAF acetylhydrolases, PAF receptor antagonists and free radical scavengers

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Inflammation of the brain in Alzheimer's disease: implications for therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5'-flanking regulatory sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Regulation of cyclooxygenase-2 expression in human mesangial cells - transcriptional inhibition by IL-13

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Interferon-gamma and interleukin 4 inhibit interleukin 1beta-induced delayed prostaglandin E(2)generation through suppression of cyclooxygenase-2 expression in human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Neuroinflammatory signaling upregulation in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Cyclooxygenase and Alzheimer's disease: implications for preventive initiatives to slow the progression of clinical dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Cyclooxygenases and the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Regional distribution of prostaglandin H synthase-2 and neuronal nitric oxide synthase in piglet brain

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Prostaglandin G/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Interleukin-1 beta induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Effects of protein kinase C activation on prostaglandin production and cyclooxygenase mRNA levels in ovine astroglia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Transforming growth factor beta1 regulates the expression of cyclooxygenase in cultured cortical astrocytes and neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

The effect of nitric oxide on cytokine-induced release of PGE2 by human cultured astroglial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Interleukin-1beta induced cyclooxygenase 2 expression and prostaglandin E2 secretion by human neuroblastoma cells: implications for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Enhanced processing of APP induced by IL-1 beta can be reduced by indomethacin and nordihydroguaiaretic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Prostaglandin E2 induces interleukin-6 synthesis in human astrocytoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Induction of cyclo-oxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: specific localization in affected neurones and axons.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Cyclooxygenase-2 stimulates production of amyloid beta-peptide in neuroblastoma x glioma hybrid NG108-15 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Cyclooxygenase-2 induction in cerebral cortex: an intracellular response to synaptic excitation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Brain oxidative stress in animal models of accelerated aging and the age-related neurodegenerative disorders, Alzheimer's disease and Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Arachidonic acid and its metabolites in cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Widespread peroxynitrite-mediated damage in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Isoprostanes, novel markers of oxidative injury, help understanding the pathogenesis of neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Identical twins discordant for presenile dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Dementia of the Alzheimer type: clinical and family study of 22 twin pairs.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

Discordance and concordance of dementia of the Alzheimer type (DAT) in monozygotic twins indicate heritable and sporadic forms of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2802%2900031-X

7 January 2021

10.1016/S0090-6980(02)00031-X

Identifiers

DOI

1 reference

5 August 2017

1 reference